BlueCrest Capital Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-87
| Closed | -$10K | – | 264 |
|
|
2020
Q1 | $10K | Buy |
+87
| New | +$10K | ﹤0.01% | 179 |
|
|
2018
Q4 | – | Sell |
-168
| Closed | -$397K | – | 1510 |
|
|
2018
Q3 | $397K | Buy |
168
+58
| +53% | +$137K | 0.01% | 868 |
|
|
2018
Q2 | $378K | Sell |
110
-1
| -0.9% | -$3.44K | 0.01% | 952 |
|
|
2018
Q1 | $315K | Buy |
+111
| New | +$315K | 0.01% | 999 |
|
|
2017
Q4 | – | Sell |
-121
| Closed | -$345K | – | 1142 |
|
|
2017
Q3 | $345K | Buy |
+121
| New | +$345K | 0.01% | 581 |
|